News Related to Pulmonary Embolism

Related coverage linked through entity extraction aliases.

FDA Approves Pembrolizumab Combinations for Platinum-Resistant Ovarian Cancer

Feb 12, 2026

The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.

FDA Removes Black Box Warning from Menopausal Hormone Therapy Products

Feb 13, 2026

The FDA has approved labeling changes to six menopausal hormone therapy products, removing boxed warnings related to cardiovascular disease, breast cancer, and probable dementia that had been in place since 2003.